182.86
Veeva Systems Inc stock is traded at $182.86, with a volume of 2.04M.
It is up +3.63% in the last 24 hours and down -18.43% over the past month.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
See More
Previous Close:
$176.46
Open:
$176.41
24h Volume:
2.04M
Relative Volume:
1.03
Market Cap:
$30.06B
Revenue:
$3.08B
Net Income/Loss:
$860.33M
P/E Ratio:
35.53
EPS:
5.1463
Net Cash Flow:
$1.35B
1W Performance:
+0.16%
1M Performance:
-18.43%
6M Performance:
-36.18%
1Y Performance:
-19.53%
Veeva Systems Inc Stock (VEEV) Company Profile
Name
Veeva Systems Inc
Sector
Industry
Phone
925-452-6500
Address
4280 HACIENDA DRIVE, PLEASANTON, CA
Compare VEEV vs TEM, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
VEEV
Veeva Systems Inc
|
182.86 | 29.01B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
55.41 | 9.56B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
40.13 | 7.36B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
77.39 | 6.46B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.02 | 4.68B | 906.14M | -52.62M | 89.62M | -0.3621 |
Veeva Systems Inc Stock (VEEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-26 | Resumed | Goldman | Sell |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-12-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-07-25 | Upgrade | TD Cowen | Hold → Buy |
| Sep-08-25 | Upgrade | JP Morgan | Neutral → Overweight |
| May-29-25 | Reiterated | Needham | Buy |
| Jan-23-25 | Downgrade | Goldman | Buy → Sell |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Nov-19-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Initiated | Exane BNP Paribas | Outperform |
| Aug-27-24 | Reiterated | Citigroup | Buy |
| Jul-09-24 | Initiated | BTIG Research | Buy |
| Oct-25-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-13-23 | Initiated | Jefferies | Buy |
| Jun-28-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-01-23 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-17-23 | Downgrade | Truist | Buy → Hold |
| Feb-23-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-04-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-06-22 | Initiated | Cowen | Market Perform |
| Dec-02-22 | Reiterated | Needham | Buy |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-19-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-27-22 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | Goldman | Buy |
| Jun-21-22 | Resumed | Guggenheim | Buy |
| Mar-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-28-22 | Initiated | Truist | Buy |
| Jan-07-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-06-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Resumed | Stifel | Buy |
| Sep-02-21 | Reiterated | BofA Securities | Buy |
| Sep-02-21 | Reiterated | JMP Securities | Mkt Outperform |
| Sep-02-21 | Reiterated | Needham | Buy |
| Sep-02-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Initiated | Cowen | Outperform |
| Mar-31-21 | Upgrade | UBS | Sell → Neutral |
| Jan-07-21 | Resumed | KeyBanc Capital Markets | Overweight |
| Dec-09-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-14-20 | Resumed | UBS | Sell |
| Aug-28-20 | Reiterated | Needham | Buy |
| Jul-23-20 | Initiated | FBN Securities | Outperform |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Jun-08-20 | Initiated | Citigroup | Buy |
| May-29-20 | Reiterated | Needham | Buy |
| Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-19-20 | Initiated | Robert W. Baird | Outperform |
| Feb-14-20 | Initiated | Piper Sandler | Overweight |
| Jan-13-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-27-19 | Reiterated | Canaccord Genuity | Hold |
| Sep-26-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-28-19 | Reiterated | Needham | Buy |
| Jun-07-19 | Initiated | Goldman | Neutral |
| May-30-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| May-24-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-27-19 | Reiterated | Needham | Buy |
View All
Veeva Systems Inc Stock (VEEV) Latest News
Veeva Systems (NYSE:VEEV) Price Target Lowered to $250.00 at Barclays - MarketBeat
Veeva Systems Inc (VEEV) Stock Price, Trades & News - GuruFocus
Veeva Systems (VEEV) to Release Earnings on Wednesday - MarketBeat
Pharmacovigilance Market Size to Reach USD 24.69 Billion by 2035 Owing to the Surging Demand for Drug Safety Monitoring Solutions Globally - GlobeNewswire Inc.
Should Diverging Views On AI Risks And CRM Strengths Require Action From Veeva Systems (VEEV) Investors? - simplywall.st
Veeva Systems (VEEV) Rises Higher Than Market: Key Facts - Yahoo Finance Singapore
Rethinking How Claims Can Drive a Competitive Advantage in Medtech - Veeva
Oppenheimer Adjusts Veeva Systems PT to $275 From $325, Maintains Outperform Rating - marketscreener.com
First Financial Bankshares Inc Buys 6,239 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Citigroup Inc. Increases Stock Position in Veeva Systems Inc. $VEEV - MarketBeat
1 reason I'd buy Veeva Systems stock and never sell - MSN
1 Reason I'd Buy Veeva Systems Stock and Never Sell - Nasdaq
Assessing Veeva Systems (VEEV) Valuation After Recent Share Price Weakness - simplywall.st
Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 68.74% Potential Upside for Investors - DirectorsTalk Interviews
Here’s Why Artisan Mid Cap Fund Sold Its Position in Veeva Systems (VEEV) - Insider Monkey
Revolve Group Achieves 19.16% Return Amid Market Volatility; Veeva Systems Declines 36.52% - Markets Mojo
Veeva Systems (VEEV) Traded Lower Despite Impressive Results - Insider Monkey
Makena Capital Management LLC Acquires 11,636 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Announces Expanded Partnership with Roche - Quantisnow
Jupiter Asset Management Ltd. Cuts Stake in Veeva Systems Inc. $VEEV - MarketBeat
Emerging Medtechs Focus on Improving Data Collection and Site Collaboration with Strategic Digital Support - Veeva
JP Morgan Adjusts Price Target While Maintaining VEEV Rating | V - GuruFocus
UBS Group Has Lowered Expectations for Veeva Systems (NYSE:VEEV) Stock Price - MarketBeat
How Cytiva Unified MedTech and BioTech Regulatory Divisions with Veeva RIM - Veeva
Veeva Systems (VEEV) Fell Due to a Broader Sector Rotation - Insider Monkey
Compass Wealth Management LLC Takes $18.69 Million Position in Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems Inc. $VEEV Shares Sold by Fiera Capital Corp - MarketBeat
2 Reasons to Like VEEV and 1 to Stay Skeptical - Yahoo Finance
Veeva Systems (VEEV) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Vanguard Group Inc. Acquires 457,806 Shares of Veeva Systems Inc. $VEEV - MarketBeat
JPMorgan Chase & Co. Purchases 159,984 Shares of Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Veeva Systems (VEEV) Upgraded by Morgan Stanley Amid Market Conc - GuruFocus
Veeva Systems upgraded at Morgan Stanley (VEEV:NYSE) - Seeking Alpha
Morgan Stanley upgrades Veeva after 45% plunge from peak to stock’s 10-year low - Investing.com Canada
VEEV: Morgan Stanley Upgrades Veeva Systems, Lowers Price Target - GuruFocus
Forecasting The Future: 9 Analyst Projections For Veeva Systems - Benzinga
Skandinaviska Enskilda Banken AB publ Raises Stock Position in Veeva Systems Inc. $VEEV - MarketBeat
Shell Asset Management Co. Has $576,000 Position in Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems Inc. (NYSE:VEEV) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Here’s why Veeva Systems (VEEV) traded down in Q4 - MSN
Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 77% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Electronic Trial Master File (eTMF) Systems Market Outlook - openPR.com
What is Veeva Systems Inc. s debt to equity ratio2025 Big Picture & Verified Trade Idea Suggestions - mfd.ru
Can Veeva Systems Inc. stock hit record highs againWeekly Trend Summary & Low Risk Growth Stock Ideas - mfd.ru
Veeva Systems Inc. $VEEV Shares Sold by TimesSquare Capital Management LLC - MarketBeat
Veeva Systems Inc. $VEEV Shares Bought by Assetmark Inc. - MarketBeat
Closing the Listening Gap to Turn Medical Insights Into Impact - Veeva
Veeva QMS BioDlink Win Highlights Valuation Gap In Veeva Systems - Sahm
Can Veeva Systems Inc. outperform under higher oil pricesInsider Selling & Real-Time Volume Trigger Notifications - mfd.ru
Rhumbline Advisers Has $60.68 Million Position in Veeva Systems Inc. $VEEV - MarketBeat
Veeva Systems Inc Stock (VEEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):